7sbo › Citations

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant.

<div class='caption-title'>More efficient membrane fusion by the Delta variant than other variants.</div>
<div class='caption-title'>Antigenic properties of purified full-length SARS-CoV-2 S proteins.</div>
<div class='caption-title'>Cryo-EM structures of full-length SARS-CoV-2 S proteins from the Delta, Kappa, and Gamma variants.</div>
Zhang J, Xiao T, Cai Y, Lavine CL, Peng H, Zhu H, Anand K, Tong P, Gautam A, Mayer ML, Walsh RM, Rits-Volloch S, Wesemann DR, Yang W, Seaman MS, Lu J, Chen B, Chen B
OpenAccess logo Science 374 1353-1360 (2021)
Related entries: 7sbk, 7sbl, 7sbp, 7sbq, 7sbr, 7sbs, 7sbt

Cited: 182 times
EuropePMC logo PMID: 34698504

Abstract

The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outcompeted previously prevalent variants and become a dominant strain worldwide. We report the structure, function, and antigenicity of its full-length spike (S) trimer as well as those of the Gamma and Kappa variants, and compare their characteristics with the G614, Alpha, and Beta variants. Delta S can fuse membranes more efficiently at low levels of cellular receptor angiotensin converting enzyme 2 (ACE2), and its pseudotyped viruses infect target cells substantially faster than the other five variants, possibly accounting for its heightened transmissibility. Each variant shows different rearrangement of the antigenic surface of the amino-terminal domain of the S protein but only makes produces changes in the receptor binding domain (RBD), making the RBD a better target for therapeutic antibodies.

Reviews - 7sbo mentioned but not cited (1)

  1. The atomic portrait of SARS-CoV-2 as captured by cryo-electron microscopy. Fertig TE, Chitoiu L, Terinte-Balcan G, Peteu VE, Marta D, Gherghiceanu M. J Cell Mol Med 26 25-34 (2022)

Articles - 7sbo mentioned but not cited (4)



Reviews citing this publication (35)

  1. The humoral response and antibodies against SARS-CoV-2 infection. Qi H, Liu B, Wang X, Zhang L. Nat Immunol 23 1008-1020 (2022)
  2. COVID-19 vaccinations: The unknowns, challenges, and hopes. Mohamed K, Rzymski P, Islam MS, Makuku R, Mushtaq A, Khan A, Ivanovska M, Makka SA, Hashem F, Marquez L, Cseprekal O, Filgueiras IS, Fonseca DLM, Mickael E, Ling I, Arero AG, Cuschieri S, Minakova K, Rodríguez-Román E, Abarikwu SO, Faten AB, Grancini G, Cabral-Marques O, Rezaei N. J Med Virol 94 1336-1349 (2022)
  3. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants. Mittal A, Khattri A, Verma V. PLoS Pathog 18 e1010260 (2022)
  4. Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity. Mengist HM, Kombe Kombe AJ, Mekonnen D, Abebaw A, Getachew M, Jin T. Semin Immunol 55 101533 (2021)
  5. Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir. Yang KS, Leeuwon SZ, Xu S, Liu WR. J Med Chem 65 8686-8698 (2022)
  6. The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2. Chan YA, Zhan SH. Mol Biol Evol 39 msab327 (2022)
  7. Small molecules in the treatment of COVID-19. Lei S, Chen X, Wu J, Duan X, Men K. Signal Transduct Target Ther 7 387 (2022)
  8. Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences. Hoteit R, Yassine HM. Vaccines (Basel) 10 919 (2022)
  9. Challenges and developments in universal vaccine design against SARS-CoV-2 variants. Zhao F, Zai X, Zhang Z, Xu J, Chen W. NPJ Vaccines 7 167 (2022)
  10. Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants. Ghimire D, Han Y, Lu M. Viruses 14 1255 (2022)
  11. Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape. Bhattacharya M, Chatterjee S, Sharma AR, Lee SS, Chakraborty C. Folia Microbiol (Praha) 68 17-28 (2023)
  12. Defending against SARS-CoV-2: The T cell perspective. Almendro-Vázquez P, Laguna-Goya R, Paz-Artal E. Front Immunol 14 1107803 (2023)
  13. SARS-CoV-2: The Monster Causes COVID-19. Song C, Li Z, Li C, Huang M, Liu J, Fang Q, Cao Z, Zhang L, Gao P, Nie W, Luo X, Kang J, Xie S, Lyu J, Zhu X. Front Cell Infect Microbiol 12 835750 (2022)
  14. Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains. de Souza AS, de Freitas Amorim VM, Guardia GDA, Dos Santos FF, Ulrich H, Galante PAF, de Souza RF, Guzzo CR. Viruses 14 827 (2022)
  15. COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines. Biswas B, Chattopadhyay S, Hazra S, Hansda AK, Goswami R. Inflamm Res 71 377-396 (2022)
  16. SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant. Meyerowitz EA, Richterman A. Infect Dis Clin North Am 36 267-293 (2022)
  17. COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development. Vo GV, Bagyinszky E, An SSA. Microorganisms 10 598 (2022)
  18. Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2. Karimian A, Behjati M, Karimian M. Arch Virol 167 1931-1946 (2022)
  19. A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment. Mohamed Y, El-Maradny YA, Saleh AK, Nayl AA, El-Gendi H, El-Fakharany EM. Biomed Pharmacother 153 113499 (2022)
  20. Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic. Alcendor DJ, Matthews-Juarez P, Smoot D, Hildreth JEK, Lamar K, Tabatabai M, Wilus D, Juarez PD. Vaccines (Basel) 10 755 (2022)
  21. SARS-CoV-2 Virology. Li Y, Li JZ. Infect Dis Clin North Am 36 251-265 (2022)
  22. SARS-CoV-2 before and after Omicron: two different viruses and two different diseases? Gili R, Burioni R. J Transl Med 21 251 (2023)
  23. The mechanisms of immune response and evasion by the main SARS-CoV-2 variants. Chen Q, Zhang J, Wang P, Zhang Z. iScience 25 105044 (2022)
  24. Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19. Wang SC, Zhang F, Zhu H, Yang H, Liu Y, Wang P, Parpura V, Wang YF. Front Endocrinol (Lausanne) 13 799521 (2022)
  25. Evolutionary dynamics of the severe acute respiratory syndrome coronavirus 2 genomes. Qian Z, Li P, Tang X, Lu J. Med Rev (2021) 2 3-22 (2022)
  26. The Physical Basis for pH Sensitivity in Biomolecular Structure and Function, With Application to the Spike Protein of SARS-CoV-2. Warwicker J. Front Mol Biosci 9 834011 (2022)
  27. The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects. Mahmoudi S, Dehkordi MM, Asgarshamsi MH. Biophys Chem 288 106824 (2022)
  28. Towards Quantum-Chemical Level Calculations of SARS-CoV-2 Spike Protein Variants of Concern by First Principles Density Functional Theory. Ching WY, Adhikari P, Jawad B, Podgornik R. Biomedicines 11 517 (2023)
  29. Biology of the SARS-CoV-2 Coronavirus. Mingaleeva RN, Nigmatulina NA, Sharafetdinova LM, Romozanova AM, Gabdoulkhakova AG, Filina YV, Shavaliyev RF, Rizvanov AA, Miftakhova RR. Biochemistry (Mosc) 87 1662-1678 (2022)
  30. Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants. Sharifi E, Yousefiasl S, Trovato M, Sartorius R, Esmaeili Y, Goodarzi H, Ghomi M, Bigham A, Moghaddam FD, Heidarifard M, Pourmotabed S, Nazarzadeh Zare E, Paiva-Santos AC, Rabiee N, Wang X, Tay FR. J Nanobiotechnology 21 199 (2023)
  31. Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion. Xue S, Han Y, Wu F, Wang Q. Protein Cell 15 403-418 (2024)
  32. Overview of immunological & virological factors driving the evolution & global spread of SARS-CoV-2 variants. Ramasamy R. Indian J Med Res 158 257-268 (2023)
  33. SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies. Guo H, Ha S, Botten JW, Xu K, Zhang N, An Z, Strohl WR, Shiver JW, Fu TM. Viruses 16 697 (2024)
  34. Structural understanding of SARS-CoV-2 virus entry to host cells. Le K, Kannappan S, Kim T, Lee JH, Lee HR, Kim KK. Front Mol Biosci 10 1288686 (2023)
  35. Cryo-electron microscopy in the study of virus entry and infection. Dutta M, Acharya P. Front Mol Biosci 11 1429180 (2024)

Articles citing this publication (142)



Quick links